Peripheral blood NDG from MM patients inhibits both proliferation (p = 0.002 inhibition range 13–75%) and IFN-γ production (p = 0.0312) (Figures 1(a)–1(d)). This evidence concerns the gene IFNG and Miyoshi myopathy.